Sato Seijiro, Nakamura Atsuhiro, Shimizu Yuki, Goto Tatsuya, Kitahara Akihiko, Koike Terumoto, Okamoto Takeshi, Tsuchida Masanori
Division of Thoracic and Cardiovascular Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Chuo-ku, Niigata, Niigata, 951-8510, Japan.
Gen Thorac Cardiovasc Surg. 2019 Feb;67(2):227-233. doi: 10.1007/s11748-018-1003-1. Epub 2018 Sep 1.
To aim of this study was to clarify the safety of simultaneous thoracic aortic endografting and combined resection of the aortic wall and thoracic malignancy in a one-stage procedure over the early and mid-term periods.
From March 2013 to December 2017, 6 patients underwent aortic endografting followed by one-stage en bloc resection of the tumor and aortic wall. Thoracic surgeons and cardiovascular surgeons discussed predicted tumor invasion range and resection site, stent placement position, stent length and size, and the surgical procedure, taking into account the safe margin.
The proximal site of aortic endografting was the: aortic arch in 2 cases (subclavian artery (SCA) occlusion in one, and SCA fenestration in one); distal arch just beneath the SCA in 2; descending aorta in 2. Pulmonary resection involved lobectomy in 2 patients, pneumonectomy in 2, and completion pneumonectomy in 1. Aortic resection was limited to the adventitia in 2 cases, extended to the media in 3, and extended to the intima in 1. An endograft-related complication, external iliac artery intimal damage requiring vessel repair, was observed in one case. No complications associated with aortic resection were observed. Two postoperative complications of atrial fibrillation and chylothorax developed. There were no surgery-related deaths. During follow-up, no late endograft-related complications such as migration or endoleaks occurred.
Early and mid-term outcomes of stent graft-related complications are acceptable. Simultaneous thoracic aortic endografting and combined resection of the aortic wall and thoracic malignancies are feasible in one stage on the same day.
本研究旨在阐明同期进行胸主动脉腔内修复术以及一期联合切除主动脉壁和胸部恶性肿瘤在早期和中期的安全性。
2013年3月至2017年12月,6例患者接受了主动脉腔内修复术,随后一期整块切除肿瘤和主动脉壁。胸外科医生和心血管外科医生讨论了预计的肿瘤侵犯范围和切除部位、支架置入位置、支架长度和尺寸以及手术步骤,同时考虑了安全切缘。
主动脉腔内修复术的近端部位:2例位于主动脉弓(1例锁骨下动脉闭塞,1例锁骨下动脉开窗);2例位于锁骨下动脉下方的远侧弓部;2例位于降主动脉。肺切除包括2例肺叶切除术、2例全肺切除术和1例完成性全肺切除术。主动脉切除2例仅限于外膜,3例扩展至中膜,1例扩展至内膜。1例患者出现了与腔内修复相关的并发症,即髂外动脉内膜损伤需要血管修复。未观察到与主动脉切除相关的并发症。术后发生了房颤和乳糜胸2种并发症。无手术相关死亡。随访期间,未发生晚期腔内修复相关并发症,如移位或内漏。
腔内修复相关并发症的早期和中期结果是可接受的。同期进行胸主动脉腔内修复术以及联合切除主动脉壁和胸部恶性肿瘤在同一天一期完成是可行的。